Long Term Efficacy of BID Administration of Anakinra and Canakinumab in Two Refractory Cases of Schnitzler Syndrome
Long Term Efficacy of BID Administration of Anakinra and Canakinumab in Two Refractory Cases of Schnitzler Syndrome Annacarla Finucci 1* , Ditto Maria Chiara 1 , Parisi Simone 1 , Borrelli Richard 1 , Piercarlo Sarzi Puttini 2 , Renato Alberto Sinico 3 and Fusaro Enrico 1 1 Rheumatology Unit, AOU Citta della Salute e della Scienza, Turin, Italy 2 Rheumatology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy 3 Medicine and Surgery Department, Milano Bicocca University, Monza, Italy * Corresponding author: Annacarla Finucci, Rheumatology Unit, AOU Citta della Salute e della Scienza, Corso Bramante 88, 10126, Turin, Italy, Tel: +390116335448; E-mail: annacarla.finucci@gmail.com Received: September 15, 2020; Accepted: October 12, 2020; Published: November 03, 2020 Citation: Annacarla Finucci, Ditto Maria Chiara, Parisi Simone, et al. Long Term Efficacy of BID Administration of Anakinra and Canakinumab in Two Refractory Cases of Sch...